DXCM — DEXCOM INC

Ownership history in Core Alternative Capital  ·  16 quarters on record

This page tracks every 13F SEC filing in which Core Alternative Capital reported a position in DEXCOM INC (DXCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q3)
Avg. % of fund
0.0%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
16
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 20 -2 -9.1% 0.00% $1K $67.29
2025 Q2 UNCHANGED 22 — 0% 0.00% $2K $87.29
2025 Q1 UNCHANGED 22 — 0% 0.00% $2K $68.29
2024 Q4 UNCHANGED 22 — 0% 0.00% $2K $77.77
2024 Q3 UNCHANGED 22 — 0% 0.00% $1K $67.04
2024 Q2 UNCHANGED 22 — 0% 0.00% $2K $113.38
2024 Q1 REDUCED 22 -130 -85.5% 0.00% $3K $138.70
2023 Q4 REDUCED 152 -514 -77.2% 0.00% $19K $124.09
2023 Q3 ADDED 666 +442 +197.3% 0.01% $62K $93.30
2023 Q2 REDUCED 224 -158 -41.4% 0.00% $29K $128.51
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DXCM price (monthly, adj. close)

Other funds also holding DXCM

As of 2025 Q4 — sorted by position size

MIG Capital, LLC 3Y 7Y 6.82% BRIDGER MANAGEMENT, LLC 3Y 7Y 4.35% Parkman Healthcare Partners LLC 3Y 3.71% Tri Locum Partners LP 3Y 3.63% SIRIOS CAPITAL MANAGEMENT L P 3Y 7Y 3.56% Soleus Capital Management, L.P. 3Y 3.18% Vestal Point Capital, LP 2.88% Alphabet Inc. 3Y 2.67% Intermede Investment Partners Ltd 3Y 7Y 2.48% ELLERSON GROUP INC /ADV 3Y 2.4%
← Back to Core Alternative Capital Holdings